Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

T Guo, D Zhang, Y Zeng, TY Huang, H Xu… - Molecular …, 2020 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-
dependent dementia. There is currently no effective treatment for AD, which may be …

Eph receptors and ephrins: therapeutic opportunities

A Barquilla, EB Pasquale - Annual review of pharmacology and …, 2015 - annualreviews.org
The e rythropoietin-p roducing h epatocellular carcinoma (Eph) receptor tyrosine kinase
family plays important roles in developmental processes, adult tissue homeostasis, and …

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

H Lu, KR Clauser, WL Tam, J Fröse, X Ye… - Nature cell …, 2014 - nature.com
The cell-biological program termed the epithelial–mesenchymal transition (EMT) confers on
cancer cells mesenchymal traits and an ability to enter the cancer stem cell (CSC) state …

An insight into cellular and molecular mechanisms underlying the pathogenesis of neurodegeneration in Alzheimer's disease

Y Ratan, A Rajput, S Maleysm, A Pareek, V Jain… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is the most prominent neurodegenerative disorder in the aging
population. It is characterized by cognitive decline, gradual neurodegeneration, and the …

Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease

AKY Fu, KW Hung, H Huang, S Gu… - Proceedings of the …, 2014 - National Acad Sciences
Alzheimer's disease (AD), characterized by cognitive decline, has emerged as a disease of
synaptic failure. The present study reveals an unanticipated role of erythropoietin-producing …

Eph receptors and ephrins as targets for cancer therapy

HQ Xi, XS Wu, B Wei, L Chen - Journal of cellular and …, 2012 - Wiley Online Library
Eph receptor tyrosine kinases and their ephrin ligands are involved in various signalling
pathways and mediate critical steps of a wide variety of physiological and pathological …

EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers

L M. Vargas, N Leal, LD Estrada, A Gonzalez… - PloS one, 2014 - journals.plos.org
The early stages of Alzheimer's disease are characterised by impaired synaptic plasticity
and synapse loss. Here, we show that amyloid-β oligomers (AβOs) activate the c-Abl kinase …

Therapeutic development in amyotrophic lateral sclerosis

M Bucchia, A Ramirez, V Parente, C Simone… - Clinical …, 2015 - Elsevier
Purpose Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in
adults. It is almost invariably lethal within a few years after the onset of symptoms. No …

[HTML][HTML] Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease

LM Vargas, W Cerpa, FJ Muñoz, S Zanlungo… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Alzheimer's disease (AD) is characterized by progressive memory loss and dementia. The
strong correlation between cognitive decline and the loss of synapses supports the idea that …

HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery

B Wu, Z Zhang, R Noberini, E Barile, M Giulianotti… - Chemistry & biology, 2013 - cell.com
Fragment-based ligand design (FBLD) approaches have become more widely used in drug
discovery projects from both academia and industry, and are even often preferred to …